Biznesradar bez reklam? Sprawdź BR Plus
Wiadomości INC
1.450+0.035(+2.47%)INC SPÓŁKA AKCYJNA
GPW - Akcje/PDA - Notowania ciągłe
Biznesradar bez reklam? Sprawdź BR Plus
Omnicell, Inc. (OMCL) delivered Q2 2026 non-GAAP earnings of $0.94 per share, surpassing analysts' $0.48 forecast (beat by 95.8%).
The post Omnicell Releases Q2 2026 Financial Results first appeared on Alphastreet.
Phathom Pharmaceuticals, Inc.
The post Phathom Pharmaceuticals Releases Q2 2026 Financial Results first appeared on Alphastreet.
Pitney Bowes Inc.
The post Pitney Bowes Releases Q2 2026 Financial Results first appeared on Alphastreet.
Scorpio Tankers Inc.
The post Scorpio Tankers Releases Q2 2026 Financial Results first appeared on Alphastreet.
Arxis, Inc.
The post Arxis Releases Q2 2026 Financial Results first appeared on Alphastreet.
Rpc, Inc.
The post Rpc Releases Q2 2026 Financial Results first appeared on Alphastreet.
Darling Ingredients Inc.
The post Darling Ingredients Releases Q2 2026 Financial Results first appeared on Alphastreet.
Xcel Energy Inc.
The post Xcel Energy Releases Q2 2026 Financial Results first appeared on Alphastreet.
Regeneron Pharmaceuticals, Inc.
The post Regeneron Pharmaceuticals Releases Q2 2026 Financial Results first appeared on Alphastreet.
Butterfly Network, Inc.
The post Butterfly Network Releases Q2 2026 Financial Results first appeared on Alphastreet.
Altria Group, Inc. (NYSE: MO) reported its second quarter 2026 earnings results today. Net revenues remained flat at $6.1 billion...
The post Key highlights from Altria’s (MO) Q2 2026 earnings results first appeared on Alphastreet.
Key Financial Metrics Revenue: $2,169 million (+12% YoY). GAAP Net Income: $853 million (+128% YoY), significantly impacted by $449 million...
The post Yum! Brands, Inc. (NYSE: YUM) – Q2 2026 Earnings first appeared on Alphastreet.
Agios Pharmaceuticals, Inc.
The post Agios Pharmaceuticals Releases Q2 2026 Financial Results first appeared on Alphastreet.
Amneal Pharmaceuticals, Inc.
The post Amneal Pharmaceuticals Releases Q2 2026 Financial Results first appeared on Alphastreet.
Viking Therapeutics, Inc.
The post Viking Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
Align Technology, Inc.
The post Align Technology Releases Q2 2026 Financial Results first appeared on Alphastreet.
Sturm, Ruger & Company, Inc.
The post Sturm, Ruger & Company Releases Q2 2026 Financial Results first appeared on Alphastreet.
PC Connection, Inc.
The post PC Connection Releases Q2 2026 Financial Results first appeared on Alphastreet.
Chipotle Mexican Grill, Inc.
The post Chipotle Mexican Grill Releases Q2 2026 Financial Results first appeared on Alphastreet.
Meta Platforms, Inc.
The post Meta Platforms Releases Q2 2026 Financial Results first appeared on Alphastreet.
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Informacje
| ISIN: | PLINCLT00015 |
|---|---|
| Data debiutu: | 09.08.2006 |
| Liczba akcji: | 15 043 099 |
| Kapitalizacja: | 21 812 494 |
| Enterprise Value: | 21 425 494 |
| Branża: | Działalność inwestycyjna |
INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom... INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom działającym w różnych sektorach. Poza prywatnymi przedsiębiorstwami, INC świadczy również usługi doradcze jednostkom samorządu terytorialnego oraz angażuje się w projekty sportowe, kulturalne i akademickie.
| Nazwa: | INC SPÓŁKA AKCYJNA |
|---|---|
| Adres: | ul. Abpa Antoniego Baraniaka 6, 61-131, Poznań, Polska |
| CEO: | Paweł Śliwiński |
| NIP: | 7781024498 |
| REGON: | 630316445 |
| KRS: | 0000028098 |
| WWW: | http://www.incsa.pl/ |
Biznesradar bez reklam? Sprawdź BR Plus

